Ad is loading...
EXAI
Price
$4.83
Change
-$0.01 (-0.21%)
Updated
Nov 19, 04:00 PM (EDT)
108 days until earnings call
RXRX
Price
$7.58
Change
+$0.51 (+7.21%)
Updated
Dec 2, 04:00 PM (EDT)
92 days until earnings call
Ad is loading...

EXAI vs RXRX

Header iconEXAI vs RXRX Comparison
Open Charts EXAI vs RXRXBanner chart's image
Exscientia
Price$4.83
Change-$0.01 (-0.21%)
Volume$96.96K
CapitalizationN/A
Recursion Pharmaceuticals
Price$7.58
Change+$0.51 (+7.21%)
Volume$1.24M
CapitalizationN/A
EXAI vs RXRX Comparison Chart
Loading...
EXAI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
EXAI vs. RXRX commentary
Dec 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXAI is a StrongSell and RXRX is a Hold.

COMPARISON
Comparison
Dec 02, 2024
Stock price -- (EXAI: $4.84 vs. RXRX: $7.07)
Brand notoriety: EXAI and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EXAI: 188% vs. RXRX: 204%
Market capitalization -- EXAI: $633.18M vs. RXRX: $2.75B
EXAI [@Biotechnology] is valued at $633.18M. RXRX’s [@Biotechnology] market capitalization is $2.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $476.43B to $0. The average market capitalization across the [@Biotechnology] industry is $2.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXAI’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • EXAI’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, EXAI is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXAI’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 6 bullish TA indicator(s).

  • EXAI’s TA Score: 3 bullish, 7 bearish.
  • RXRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than EXAI.

Price Growth

EXAI (@Biotechnology) experienced а 0.00% price change this week, while RXRX (@Biotechnology) price change was +24.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.61%. For the same industry, the average monthly price growth was +2.63%, and the average quarterly price growth was +11.51%.

Reported Earning Dates

EXAI is expected to report earnings on Mar 20, 2025.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+4.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.75B) has a higher market cap than EXAI($633M). EXAI YTD gains are higher at: -24.493 vs. RXRX (-28.296). EXAI has higher annual earnings (EBITDA): -135.58M vs. RXRX (-350.86M). RXRX has more cash in the bank: 428M vs. EXAI (244M). EXAI has less debt than RXRX: EXAI (18.6M) vs RXRX (90.6M). RXRX has higher revenues than EXAI: RXRX (64.6M) vs EXAI (17.1M).
EXAIRXRXEXAI / RXRX
Capitalization633M2.75B23%
EBITDA-135.58M-350.86M39%
Gain YTD-24.493-28.29687%
P/E RatioN/AN/A-
Revenue17.1M64.6M26%
Total Cash244M428M57%
Total Debt18.6M90.6M21%
TECHNICAL ANALYSIS
Technical Analysis
EXAIRXRX
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 22 days ago
81%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
EXAI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLXAX30.350.39
+1.30%
Catalyst Energy Infrastructure A
JLGMX85.020.67
+0.79%
JPMorgan Large Cap Growth R6
GIDWX18.190.07
+0.39%
Goldman Sachs US Eq Div and Premium R6
BABDX13.160.04
+0.30%
BlackRock Global Dividend Inv A
MPEYX9.94-0.04
-0.40%
MassMutual Strat Emerg Mkts Svc

EXAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXAI has been loosely correlated with RXRX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXAI
1D Price
Change %
EXAI100%
N/A
RXRX - EXAI
55%
Loosely correlated
+10.82%
BEAM - EXAI
48%
Loosely correlated
+0.63%
CRSP - EXAI
43%
Loosely correlated
+0.65%
XERS - EXAI
42%
Loosely correlated
-4.93%
NTLA - EXAI
42%
Loosely correlated
+2.70%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+10.82%
BEAM - RXRX
63%
Loosely correlated
+0.63%
CRSP - RXRX
58%
Loosely correlated
+0.65%
EXAI - RXRX
56%
Loosely correlated
N/A
PRME - RXRX
55%
Loosely correlated
-0.30%
NTLA - RXRX
53%
Loosely correlated
+2.70%
More